» GeNeuro: launch of the 1st personalized medicine clinical trial evaluating temelimab against COVID long MyPharma Editions
» GeNeuro: launch of the 1st personalized medicine clinical trial evaluating temelimab against COVID long MyPharma Editions
Posted on Wednesday, November 16, 2022 GeNeuro announced the recruitment of the first patients in its phase 2 trial evaluating temelimab against long COVID, at the post-COVID consultation of the Geneva University Hospitals (HUG) in Geneva (reference center) as well as in all other Swiss centers participants in the study, namely Inselspital in Bern, REHAB Basel in Basel, Kantonsspital Graubünden…
View On WordPress










